Search
Powered By HealthLine
Special Offers
TV Specials
 Learn about an Effective Alzheimer's Medication
 Bipolar Education Health Center
 Osteoarthritis of the Knee Solution Center
 Heartburn Education Center
 Breast Cancer Health Center
 Crohn's Disease Health Center
 Schizophrenia Education Center
Top Features
 Depression
 Schizophrenia
 Breast Cancer
 Bipolar
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Combined Imaging Improves Colorectal Cancer Diagnosis

Computer tomography and positron emission tomography at once benefits patients, study finds

By Ed Edelson
HealthDay Reporter


Related Encyclopedia
 border=
Adenocarcinoma of the Lung and Brain Metastases
Basal Cell Carcinoma
Bladder Cancer
Bone Cancer
More...

Related Healthscout Videos
 border=
Zapping Vocal Tumors
Keep Away Ovarian Cancer
Breakthrough for Fatal Lung Disease
Preventing Breast Cancer
More...

Related Animations
 border=
Breast Self-Exam Video
Colon Cancer
More...

Related Drug Information
 border=
Epogen
Iressa
Procrit
Topamax
More...

Related News Articles
 border=
Diets May Raise Cancer Risk for Poor, Urban Women
Cancer Patients Gain From Reporting Symptoms Online
Fewer Women Getting Mammograms
Research Can Help Close Cancer 'Race Gap'
More...

TUESDAY, Dec. 5 (HealthDay News) -- The combination of two imaging techniques -- positron emission tomography and computed tomography -- provides quicker and more precise information to guide the treatment of colorectal cancer, German doctors report.

Exact and complete information on the "stage" -- or severity -- of a tumor is critical, said the physicians at University Hospital Essen. Typically, getting that information requires a series of imaging sessions, each one supplying a segment of the picture.

Text Continues Below



The German study compared the use of newly available positron emission tomography (PET)/computed tomography (CT) devices to older, conventional techniques for diagnosis of 47 patients with colorectal cancer.

CT alone correctly diagnosed 52 percent of the cancers, the report said. CT followed by PET was accurate in 64 percent of the cases. But the PET/CT combination was 22 percent more accurate in defining the exact stage of the tumor.

Most important, the PET/CT combination was most successful in designing treatment for individual patients, the report said. It changed therapy management in four of the patients.

"Based on the results of our study, we have integrated PET/CT colonography in our daily clinical routine," said Dr. Gerald Antoch, associate professor of radiology at Essen, and lead author of the report.

But Antoch cautioned that the study "must be considered preliminary," and "further studies are required to confirm these results in a larger patient cohort."

Such a study will be done at Essen, Antoch said.

"Whole-body PET/CT colonography as an all-in-one staging modality seems feasible to provide an alternative to the multimodality, multi-step staging in patients with colorectal cancer," the report stated. "It is less time-consuming than a conventional multi-step approach... Thus, it represents a psychological and physical advantage when considering the burden to the patient."

Page:  1 | 2 | Next >>

Copyright © 2006 ScoutNews LLC. All rights reserved.
Last updated 12/5/2006

Related Links
 border=
From Healthscout's partner site on acid reflux, AcidRefluxConnection.com
SYMPTOMS: Learn about the symptoms of acid reflux disease
DRUGS: Common medications used to treat heartburn
TREATMENT: Lifestyle changes, medication, and surgeryoptions





New Features

New ADHD Site!

SOURCES: Gerald Antoch, M.D., associate professor of radiology, University Hospital Essen, Germany; Christiaan Schiepers, M.D., professor of molecular and medical pharmacology, University of California, Los Angeles, Medical Center; Dec. 6, 2006, Journal of the American Medical Association


About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service   Site Map